Hematopoiesis & Alzheimer's Disease

The formation of blood cells, hematopoiesis, has been exploited for the potential use as a therapy in Alzheimer’s disease. Decreased levels of lymphocytes and proteins involved in stem cell recruitment are found in early stages of Alzheimer’s disease. Here is the latest research on hematopoiesis and Alzheimer’s disease.

September 30, 2021
Open Access

The SMYD1 and skNAC transcription factors contribute to neurodegenerative diseases.

Brain, Behavior, & Immunity Health
R Dayne MayfieldHaley O Tucker
September 1, 2021
Review

Exploiting dynamic enhancer landscapes to decode macrophage and microglia phenotypes in health and disease.

Molecular Cell
Ty D TroutmanChristopher K Glass
June 7, 2021
Review
Open Access

Humanized Mice for Infectious and Neurodegenerative disorders.

Retrovirology
Prasanta K DashHoward E Gendelman
May 18, 2021
Review
Open Access

Bone-to-Brain: A Round Trip in the Adaptation to Mechanical Stimuli.

Frontiers in Physiology
Laura Gerosa, Giovanni Lombardi
May 14, 2021
Open Access

TREM2 promotes natural killer cell development in CD3-CD122+NK1.1+ pNK cells.

BMC Immunology
Hwa-Youn LeeEun-Mi Kim
March 18, 2021
Review
Open Access

The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes.

Frontiers in Pharmacology
Roberta LattanziAldo Badiani
March 3, 2021
Review

Stem cell in neurodegenerative disorders; an emerging strategy.

International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
Milad Ahani-NahayatiAli Hassanzadeh
February 10, 2021
Open Access

A zebrafish model of granulin deficiency reveals essential roles in myeloid cell differentiation.

Blood Advances
Clyde A CampbellRaquel Espín-Palazón
December 29, 2020
Preprint
Open Access

TREM2 Promotes Natural Killer Cell Development in CD3-CD122+NK1.1+ pNK Cells

ResearchSquare
Hwa-Youn LeeEun-Mi Kim
October 30, 2020
Review
Open Access

Mutations in normal tissues-some diagnostic and clinical implications.

BMC Medicine
Clare Fiala, Eleftherios P Diamandis
May 29, 2020
Open Access

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich's Ataxia

Molecular Therapy. Methods & Clinical Development
Celine J RoccaStephanie Cherqui
February 14, 2020
Case Report

Prenatal diagnosis of cerebro-oculo-facio-skeletal syndrome: Report of three fetuses and review of the literature

American Journal of Medical Genetics. Part a
Pauline Le Van QuyenMaria C Antal
January 1, 2020
Open Access

Mechanistic and Translational Advances Using iPSC-Derived Blood Cells.

Journal of Experimental Pathology
Christopher S ThomDeborah L French
July 1, 2019

Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology

Neurobiology of Aging
Oksana DmytriyevaStanislava Pankratova
June 27, 2019
Review
Open Access

Role of Lipid Rafts in Hematopoietic Stem Cells Homing, Mobilization, Hibernation, and Differentiation

Cells
Munther AlomariDeena Ababneh
May 22, 2019
Open Access

Commentary on Some Recent Theses Relevant to Combating Aging: June 2019

Rejuvenation Research
Benjamin Zealley, Aubrey D N J de Grey
April 10, 2019
Open Access

Neuroprotective effects of EpoL against oxidative stress induced by soluble oligomers of Aβ peptide

Redox Biology
C CastilloJorge Fuentealba

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved
/feed-previews/hematopoiesis-alzheimers-disease/a821b3fb-abb7-4dfe-9f5e-76a90e512a94